BTG/CBI Career Panel (LOCATION CHANGE)

March 5, 2020 - 3:30pm

E241, the Gunn Rotunda in the ChEM-H/Neuroscience Building

Or join by ZOOM:
Join from PC, Mac, Linux, iOS or Android: https://stanford.zoom.us/j/659974702
Dial in: Dial: +1 650 724 9799 (US, Canada, Caribbean Toll) or +1 833 302 1536 (US, Canada, Caribbean Toll Free)
Meeting ID: 659 974 702

Open to all

Join the Biotech Training Grant and Chemistry/Biology Interface Training Program for a panel of recent alumni of STEM PhDs. Panelists include:

Emma Flores-Kim

Scientific Affairs Manager, NeoTract

Bio to come

Kirthana Ganesha

Senior Scientific Research

Genentech

I received my PhD in immunology from Northwestern University in Chicago. My research was focused on understanding how mast cell responses were regulated in food allergy. Specifically, I was investigating the interactions between mast cells and regulatory T cells and used a mouse model of food allergy to interrogate this relationship. I left Northwestern to pursue a postdoc in immunometabolism at UCSF. Initially, my work centered on determining the contribution of innate immune cells to the development of obesity and metabolic disease. It then transitioned to more broadly investigating the metabolic requirements of an immune response. During my postdoc, I grew more interested in drug development and pursuing research that would contribute to the pipeline. After I completed my postdoc, I joined Genentech as a Senior Scientific Researcher in 2012 and now work in the area of muco-obstructive lung diseases.

D.J. Kleinbaum, PhD

Co-founder & Co-CEO

Emerald Cloud Lab, Inc

D.J. Kleinbaum is the Co-founder and Co-CEO of Emerald Cloud Lab and Emerald Therapeutics. In addition to his work at Emerald, he also serves on the Swartz Center for Entrepreneurship Advisory Board, Automated Science External Advisory Board, and the Mellon College of Science Dean's Council, all at Carnegie Mellon University. Dr. Kleinbaum holds a PhD in Chemistry from Stanford University and a BS in Biological Sciences with concentrations in Computational Biology and Biochemistry from Carnegie Mellon University.

Holly Korir

Senior Clinical Development Engineer

da Vinci single port

Holly Korir was a Biotechnology Training Program trainee from 2011-14 during a PhD in mechanical engineering at Stanford. Her research in the Neuromuscular Biomechanics Lab of Professor Scott Delp focused on optogenetic stimulation and inhibition of motor neurons and muscle. In 2014, she completed the BTG industry internship at Penumbra, Inc., as a manufacturing engineering intern for a neurovascular catheter project. After graduate school, Holly worked at a medical device incubator developing a pill-sized drug delivery device. She joined Intuitive in 2015 and currently works as a Senior Clinical Development Engineer on product and procedure development for the da Vinci Single Port surgical robot.